PLC-β1 and cell differentiation: An insight into myogenesis and osteogenesis.

Citation data:

Advances in biological regulation, ISSN: 2212-4934, Vol: 63, Page: 1-5

Publication Year:
2017
Usage 14
Abstract Views 11
Link-outs 3
Captures 14
Readers 14
Citations 13
Citation Indexes 13
Repository URL:
http://www.sciencedirect.com/science/article/pii/S2212492616300562
PMID:
27776973
DOI:
10.1016/j.jbior.2016.10.005
Author(s):
Ramazzotti, Giulia; Faenza, Irene; Fiume, Roberta; Billi, Anna Maria; Manzoli, Lucia; Mongiorgi, Sara; Ratti, Stefano; McCubrey, James A; Suh, Pann-Ghill; Cocco, Lucio; Follo, Matilde Y Show More Hide
Publisher(s):
Elsevier BV
Tags:
Biochemistry, Genetics and Molecular Biology
review description
Phosphoinositide-phospholipase C-β1 (PLC-β1) plays a crucial role in the initiation of the genetic program responsible for muscle differentiation and osteogenesis. During myogenic differentiation of murine C2C12 myoblasts, PLC-β1 signaling pathway involves the Inositol Polyphosphate Multikinase (IPMK) and β-catenin as downstream effectors. By means of c-jun binding to cyclin D3 promoter, the activation of PLC-β1 pathway determines cyclin D3 accumulation. However, osteogenesis requires PLC-β1 expression and up-regulation but it does not affect cyclin D3 levels, suggesting that the two processes require the activation of different mediators.